ATE243695T1 - 5-bicycloindolverbindungen - Google Patents

5-bicycloindolverbindungen

Info

Publication number
ATE243695T1
ATE243695T1 AT99930958T AT99930958T ATE243695T1 AT E243695 T1 ATE243695 T1 AT E243695T1 AT 99930958 T AT99930958 T AT 99930958T AT 99930958 T AT99930958 T AT 99930958T AT E243695 T1 ATE243695 T1 AT E243695T1
Authority
AT
Austria
Prior art keywords
compounds
bicycloindole
disclosed
ht1d receptor
migrane
Prior art date
Application number
AT99930958T
Other languages
English (en)
Inventor
Abdelmalik Slassi
Jalaj Arora
Ashok Tehim
Original Assignee
Nps Allelix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Allelix Corp filed Critical Nps Allelix Corp
Application granted granted Critical
Publication of ATE243695T1 publication Critical patent/ATE243695T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Indole Compounds (AREA)
AT99930958T 1998-07-17 1999-07-15 5-bicycloindolverbindungen ATE243695T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/116,946 US6329390B1 (en) 1998-07-17 1998-07-17 5-Bicycloindole compounds
PCT/CA1999/000639 WO2000004019A1 (en) 1998-07-17 1999-07-15 5-bicycloindole compounds

Publications (1)

Publication Number Publication Date
ATE243695T1 true ATE243695T1 (de) 2003-07-15

Family

ID=22370203

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99930958T ATE243695T1 (de) 1998-07-17 1999-07-15 5-bicycloindolverbindungen

Country Status (8)

Country Link
US (1) US6329390B1 (de)
EP (1) EP1098896B1 (de)
JP (1) JP2002520412A (de)
AT (1) ATE243695T1 (de)
AU (1) AU767274B2 (de)
CA (1) CA2343748A1 (de)
DE (1) DE69909097D1 (de)
WO (1) WO2000004019A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2508290C (en) * 2002-12-20 2017-02-28 Ciba Specialty Chemicals Holding Inc. Synthesis of amines and intermediates for the synthesis thereof
CN102936240A (zh) * 2012-10-30 2013-02-20 浙江省医学科学院 一种(r)-5-取代-3-(n-苄氧羰基吡咯烷-2-基羰基)-1h-吲哚的合成方法
WO2025104491A1 (en) * 2023-11-14 2025-05-22 Mindset Pharma Inc. Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto
WO2025104490A1 (en) * 2023-11-14 2025-05-22 Mindset Pharma Inc. Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407447D0 (en) * 1994-04-14 1994-06-08 Glaxo Group Ltd Chemical compounds
AU738668B2 (en) * 1996-11-26 2001-09-20 Nps Allelix Corp. 5-cyclo indole compounds as 5-HT1D receptor ligands

Also Published As

Publication number Publication date
AU4765199A (en) 2000-02-07
CA2343748A1 (en) 2000-01-27
EP1098896B1 (de) 2003-06-25
US6329390B1 (en) 2001-12-11
WO2000004019A1 (en) 2000-01-27
DE69909097D1 (de) 2003-07-31
AU767274B2 (en) 2003-11-06
EP1098896A1 (de) 2001-05-16
JP2002520412A (ja) 2002-07-09

Similar Documents

Publication Publication Date Title
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
MX9702865A (es) Agentes estrogenicos.
TR199800585T2 (xx) COX-2 �nhibit�rleri Olarak (Metils�lfonil)Fenil-2-(5H)-Furanonlar.
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
BR0109703A (pt) Derivados de piperazina
ATE290382T1 (de) Heterozyklische kalium-kanal inhibitoren
DE69940480D1 (de) Carbocyclische kaliumkanalhemmer
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
YU21702A (sh) Supstituisani indoli za moduliranje nfkb aktivnosti
NO20012977D0 (no) N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet
EP1918287A3 (de) LPA-Rezeptor-Agonist und -Antagonist sowie Verwendungsverfahren dafür
GB9801690D0 (en) Therapeutic agents
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
DE69820632D1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)-piperazin-derivate
ATE211732T1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
BR0013311A (pt) Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
TR200001452T2 (tr) Bifenilamidin türevleri.
MY117381A (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties